|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen WQ, Zheng RS, Baade PD, Zhang SW,
Zeng HM, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in
China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li H, Wang X, Wen C, Huo Z, Wang W, Zhan
Q, Cheng D, Chen H, Deng X, Peng C and Shen B: Long noncoding RNA
NORAD, a novel competing endogenous RNA, enhances the
hypoxia-induced epithelial-mesenchymal transition to promote
metastasis in pancreatic cancer. Mol Cancer. 16:1692017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
von Ahrens D, Bhagat TD, Nagrath D, Maitra
A and Verma A: The role of stromal cancer-associated fibroblasts in
pancreatic cancer. J Hematol Oncol. 10:762017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tang D, Wang D, Yuan Z, Xue X, Zhang Y, An
Y, Chen J, Tu M, Lu Z, Wei J, et al: Persistent activation of
pancreatic stellate cells creates a microenvironment favorable for
the malignant behavior of pancreatic ductal adenocarcinoma. Int J
Cancer. 132:993–1003. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu Q, Tian Y, Zhang J, Zhang H, Gu F, Lu
Y, Zou S, Chen Y, Sun P, Xu M, et al: Functions of pancreatic
stellate cell-derived soluble factors in the microenvironment of
pancreatic ductal carcinoma. Oncotarget. 8:102721–102738. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Razidlo GL, Burton KM and McNiven MA:
Interleukin-6 promotes pancreatic cancer cell migration by rapidly
activating the small GTPase CDC42. J Biol Chem. 293:11143–11153.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lei J, Huo X, Duan W, Xu Q, Li R, Ma J, Li
X, Han L, Li W, Sun H, et al: α-Mangostin inhibits hypoxia-driven
ROS-induced PSC activation and pancreatic cancer cell invasion.
Cancer Lett. 347:129–138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Erkan M, Kurtoglu M and Kleeff J: The role
of hypoxia in pancreatic cancer: A potential therapeutic target?
Expert Rev Gastroenterol Hepatol. 10:301–316. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cao L, Xiao X, Lei J, Duan W, Ma Q and Li
W: Curcumin inhibits hypoxia-induced epithelial-mesenchymal
transition in pancreatic cancer cells via suppression of the
hedgehog signaling pathway. Oncol Rep. 35:3728–3734. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sada M, Ohuchida K, Horioka K, Okumura T,
Moriyama T, Miyasaka Y, Ohtsuka T, Mizumoto K, Oda Y and Nakamura
M: Hypoxic stellate cells of pancreatic cancer stroma regulate
extracellular matrix fiber organization and cancer cell motility.
Cancer Lett. 372:210–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shanmugam MK, Rane G, Kanchi MM, Arfuso F,
Chinnathambi A, Zayed ME, Alharbi SA, Tan BK, Kumar AP and Sethi G:
The multifaceted role of curcumin in cancer prevention and
treatment. Molecules. 20:2728–2769. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Allegra A, Innao V, Russo S, Gerace D,
Alonci A and Musolino C: Anticancer activity of curcumin and its
analogues: Preclinical and clinical studies. Cancer Invest.
35:1–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li W, Wang Z, Xiao X, Han L, Wu Z, Ma Q
and Cao L: Curcumin attenuates hyperglycemia-driven EGF-induced
invasive and migratory abilities of pancreatic cancer via
suppression of the ERK and AKT pathways. Oncol Rep. 41:650–658.
2019.PubMed/NCBI
|
|
16
|
Bachem MG, Schneider E, Gross H,
Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grunert A and
Adler G: Identification, culture, and characterization of
pancreatic stellate cells in rats and humans. Gastroenterology.
115:421–432. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun L, Chen K, Jiang Z, Chen X, Ma J, Ma Q
and Duan W: Indometacin inhibits the proliferation and activation
of human pancreatic stellate cells through the downregulation of
COX-2. Oncol Rep. 39:2243–2251. 2018.PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ferdek PE and Jakubowska MA: Biology of
pancreatic stellate cells-more than just pancreatic cancer.
Pflugers Arch. 469:1039–1050. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Masamune A, Kikuta K, Watanabe T, Satoh K,
Hirota M and Shimosegawa T: Hypoxia stimulates pancreatic stellate
cells to induce fibrosis and angiogenesis in pancreatic cancer. Am
J Physiol Gastrointest Liver Physiol. 295:G709–G717. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nagathihalli NS, Castellanos JA, VanSaun
MN, Dai X, Ambrose M, Guo Q, Xiong Y and Merchant NB: Pancreatic
stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness
of pancreatic intraepithelial neoplasia and cancer cells.
Oncotarget. 7:65982–65992. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ghandadi M and Sahebkar A: Curcumin: An
effective inhibitor of interleukin-6. Curr Pharm Des. 23:921–931.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hamada S, Masamune A, Yoshida N, Takikawa
T and Shimosegawa T: IL-6/STAT3 plays a regulatory role in the
interaction between pancreatic stellate cells and cancer cells. Dig
Dis Sci. 61:1561–1571. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Neuzillet C, Hammel P, Tijeras-Raballand
A, Couvelard A and Raymond E: Targeting the Ras-ERK pathway in
pancreatic adenocarcinoma. Cancer Metastasis Rev. 32:147–162. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cao L, Liu J, Zhang L, Xiao X and Li W:
Curcumin inhibits H2O2-induced invasion and migration of human
pancreatic cancer via suppression of the ERK/NF-κB pathway. Oncol
Rep. 36:2245–2251. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li W, Ma Q, Liu J, Han L, Ma G, Liu H,
Shan T, Xie K and Wu E: Hyperglycemia as a mechanism of pancreatic
cancer metastasis. Front Biosci (Landmark Ed). 17:1761–1774. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hirakawa T, Yashiro M, Doi Y, Kinoshita H,
Morisaki T, Fukuoka T, Hasegawa T, Kimura K, Amano R and Hirakawa
K: Pancreatic fibroblasts stimulate the motility of pancreatic
cancer cells through IGF1/IGF1R signaling under hypoxia. PLoS One.
11:e01599122016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu H, Ma Q, Xu Q, Lei J, Li X, Wang Z and
Wu E: Therapeutic potential of perineural invasion, hypoxia and
desmoplasia in pancreatic cancer. Curr Pharm Des. 18:2395–2403.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mato E, Lucas M, Petriz J, Gomis R and
Novials A: Identification of a pancreatic stellate cell population
with properties of progenitor cells: New role for stellate cells in
the pancreas. Biochem J. 421:181–191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thomas D and Radhakrishnan P:
Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis.
Mol Cancer. 18:142019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang XP, Liu SL, Xu JF, Cao SG, Li Y and
Zhou YB: Pancreatic stellate cells increase pancreatic cancer cells
invasion through the hepatocyte growth factor /c-Met/survivin
regulated by P53/P21. Exp Cell Res. 357:79–87. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nan L, Qin T, Xiao Y, Qian W, Li J, Wang
Z, Ma J, Ma Q and Wu Z: Pancreatic stellate cells facilitate
perineural invasion of pancreatic cancer via HGF/c-Met pathway.
Cell Transplant. 28:1289–1298. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu YS, Chung I, Wong WF, Masamune A, Sim
MS and Looi CY: Paracrine IL-6 signaling mediates the effects of
pancreatic stellate cells on epithelial-mesenchymal transition via
Stat3/Nrf2 pathway in pancreatic cancer cells. Biochim Biophys Acta
Gen Subj. 1861:296–306. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lei J, Ma J, Ma Q, Li X, Liu H, Xu Q, Duan
W, Sun Q, Xu J, Wu Z and Wu E: Hedgehog signaling regulates hypoxia
induced epithelial to mesenchymal transition and invasion in
pancreatic cancer cells via a ligand-independent manner Mol Cancer
12. 66:2013.
|
|
35
|
Li N, Li Y, Li Z, Huang C, Yang Y, Lang M,
Cao J, Jiang W, Xu Y, Dong J and Ren H: Hypoxia inducible factor 1
(HIF-1) recruits macrophage to activate pancreatic stellate cells
in pancreatic ductal adenocarcinoma. Int J Mol Sci. 17(pii):
E7992016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Eguchi D, Ikenaga N, Ohuchida K, Kozono S,
Cui L, Fujiwara K, Fujino M, Ohtsuka T, Mizumoto K and Tanaka M:
Hypoxia enhances the interaction between pancreatic stellate cells
and cancer cells via increased secretion of connective tissue
growth factor. J Surg Res. 181:225–233. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li W, Cao L, Han L, Xu Q and Ma Q:
Superoxide dismutase promotes the epithelial-mesenchymal transition
of pancreatic cancer cells via activation of the H2O2/ERK/NF-κB
axis. Int J Oncol. 46:2613–2620. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vainer N, Dehlendorff C and Johansen JS:
Systematic literature review of IL-6 as a biomarker or treatment
target in patients with gastric, bile duct, pancreatic and
colorectal cancer. Oncotarget. 9:29820–29841. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pop VV, Seicean A, Lupan I, Samasca G and
Burz CC: IL-6 roles-molecular pathway and clinical implication in
pancreatic cancer-A systemic review. Immunol Lett. 181:45–50. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Goumas FA, Holmer R, Egberts JH,
Gontarewicz A, Heneweer C, Geisen U, Hauser C, Mende MM, Legler K,
Röcken C, et al: Inhibition of IL-6 signaling significantly reduces
primary tumor growth and recurrencies in orthotopic xenograft
models of pancreatic cancer. Int J Cancer. 137:1035–1046. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li W, Jiang Z, Xiao X, Wang Z, Wu Z, Ma Q
and Cao L: Curcumin inhibits superoxide dismutase-induced
epithelial-to-mesenchymal transition via the PI3K/Akt/NF-κB pathway
in pancreatic cancer cells. Int J Oncol. 52:1593–1602.
2018.PubMed/NCBI
|
|
42
|
Shao S, Duan W, Xu Q, Li X, Han L, Li W,
Zhang D, Wang Z and Lei J: Curcumin suppresses hepatic stellate
cell-induced hepatocarcinoma angiogenesis and invasion through
downregulating CTGF. Oxid Med Cell Longev. 2019:81485102019.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang Q, Qu C, Xie F, Chen L, Liu L, Liang
X, Wu X, Wang P and Meng Z: Curcumin suppresses
epithelial-to-mesenchymal transition and metastasis of pancreatic
cancer cells by inhibiting cancer-associated fibroblasts. Am J
Cancer Res. 7:125–133. 2017.PubMed/NCBI
|
|
44
|
Kanai M, Yoshimura K, Asada M, Imaizumi A,
Suzuki C, Matsumoto S, Nishimura T, Mori Y, Masui T, Kawaguchi Y,
et al: A phase I/II study of gemcitabine-based chemotherapy plus
curcumin for patients with gemcitabine-resistant pancreatic cancer.
Cancer Chemother Pharmacol. 68:157–164. 2011. View Article : Google Scholar : PubMed/NCBI
|
